Rituximab Market - Top Companies and Manufacturers

Companies Dominating the Rituximab Landscape

Amgen Inc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Henlius Biotech, Inc.
Nordic Nanovector ASA
Biocon Biologics Ltd
Pfizer Inc.
Chugai Pharmaceuticals
Zenyaku Kogyo Co. Ltd,
SymBio Pharmaceuticals
Daiichi Sankyo
Kyowa Kirin Co. Ltd

Browse Key Market Insights with Data Illustration:

Rituximab Market Size & Share, Global Forecast Report 2037

In the News

Nordic Nanovector ASA announced the successful outcomes of the Archer-1 phase B trial for treating second-line follicular lymphoma (2L FL), investing Betalutin (177Lu lilotomab satetraxetan) in combination with rituximab (RTX).
Biocon Biologics Ltd has signed an agreement with the Clinton Health Initiative (CHAI) to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of the Cancer Access Partnership (CAP).

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of rituximab is estimated at USD 5.11 billion.

The rituximab market size was over USD 4.03 billion in 2024 and is anticipated to cross USD 27.13 billion by 2037, witnessing more than 15.8% CAGR during the forecast period i.e., between 2025-2037. Increasing demand for monoclonal antibodies, increasing collaborations for the development of new products and investment in healthcare sector will drive the market growth.

North America industry is anticipated to dominate majority revenue share of 45% by 2037, fuelled by increased government spending on cancer research as well as the presence of major pharmaceutical companies in the region.

The major players in the market are Amgen Inc, Henlius Biotech, Inc., Nordic Nanovector ASA, Biocon Biologics Ltd, Pfizer Inc., Chugai Pharmaceuticals, Zenyaku Kogyo Co. Ltd, SymBio Pharmaceuticals, Daiichi Sankyo, Kyowa Kirin Co. Ltd

Rituximab Market - Top Companies and Manufacturers

Companies Dominating the Rituximab Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the rituximab market?

Why is the rituximab sector gaining traction in near future?

Which region accounted for the largest rituximab industry share?

Who are the major rituximab players?